You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 5,856,442

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,856,442

Title:	Transcripts of the MHC class I HLA-G gene and their applications
Abstract:	Transcripts of the major histocompatibility complex (MHC) Class I HLA-G gene which are present in foetal trophoblasts and/or in adult circulating mono-nuclear cells, as well as methods of using these. Either the said transcripts comprise, in succession in the 5\' to 3\' direction: a fragment encoding the signal peptide (exon 1), a fragment encoding the .alpha.1 domain (exon 2), a fragment encoding the .alpha.2 domain (exon 3), a fragment encoding the transmembrane TM domain (exon 5), a fragment encoding the cytoplasmic domain (exon 6) and the 3\' untranslated fragment (exon 8), which sequence is designated HLA-G4, or the said transcripts comprise intron 4.
Inventor(s):	Carosella; Edgardo Delfino (Paris, FR), Moreau; Philippe (Viry-Chatillon, FR), Gluckman; Eliane (Paris, FR), Kirszenbaum; Marek (Orsay, FR)
Assignee:	Commissariat a l\'Energie Atomique (Paris, FR)
Application Number:	08/406,057
Patent Claims:	1. A protein encoded by a transcript of the human MHC HLA-G gene, wherein said transcript comprises in succession from the 5' end to the 3' end: a sequence encoding the .alpha.2 domain; a sequence encoding the transmembrane domain; and a sequence encoding the cytoplasmic domain; said transcript not containing a sequence encoding the .alpha.3 domain. 2. The protein of claim 1, wherein said transcript additionally comprises: a sequence encoding the signal peptide located on the 5' side of said sequence encoding the .alpha.2 domain; a sequence encoding the .alpha.1 domain located between said sequence encoding the signal peptide and said sequence encoding the .alpha.2 domain; and a sequence encoding the 3' untranslated region located on the 3' side of said sequence encoding the cytoplasmic domain. 3. A polypeptide which has the amino acid sequence of SEQ ID NO:7. 4. The protein of claim 1, wherein said transcript additionally comprises: a sequence encoding the 3' untranslated region located on the 3' side of said sequence encoding the cytoplasmic domain. 5. The protein of claim 4, wherein said transcript has the nucleotide sequence of SEQ ID NO:1. 6. The protein of claim 1, wherein said transcript additionally comprises: a sequence encoding the signal peptide located on the 5' side of said sequence encoding the .alpha.2 domain; and a sequence encoding the .alpha.1 domain located between said sequence encoding the signal peptide and said sequence encoding the transmembrane domain. 7. A protein encoded by a transcript of the human MHC HLA-G gene, wherein said transcript comprises in succession from the 5' end to the 3' end: a sequence encoding the signal peptide; a sequence encoding the .alpha.1 domain; a sequence encoding the .alpha.3 domain; intron 4; and a sequence encoding the transmembrane domain. 8. The protein of claim 7, wherein said transcript additionally comprises: a sequence encoding the .alpha.2 domain located between said sequence encoding the .alpha.1 domain and said a sequence encoding the .alpha.3 domain; a sequence encoding the cytoplasmic domain located on the 3' side of said sequence encoding the transmembrane domain; and a sequence encoding the 3' untranslated region located on the 3' side of said sequence encoding the cytoplasmic domain. 9. A polypeptide having the amino acid sequence of SEQ ID NO:8. 10. The protein of claim 7, wherein said transcript additionally comprises: a sequence encoding the cytoplasmic domain located on the 3' side of said sequence encoding the transmembrane domain; and a sequence encoding the 3' untranslated region located on the 3' side of said sequence encoding the cytoplasmic domain. 11. A polypeptide which has the amino acid sequence of SEQ ID NO:9. 12. The protein of claim 7, wherein said transcript additionally comprises: a sequence encoding the .alpha.2 domain located between said sequence encoding the .alpha.1 domain and said a sequence encoding the .alpha.3 domain; and a sequence encoding the 3' untranslated region located on the 3' side of said sequence encoding transmembrane domain. 13. The peptide of claim 7, wherein said transcript additionally comprises: a sequence encoding the .alpha.2 domain located between said sequence encoding the .alpha.1 domain and said a sequence encoding the .alpha.3 domain. 14. A composition, comprising the protein of claim 1 and a carrier. 15. A composition, comprising the protein of claim 7 and a carrier. 16. A method for producing an antibody, comprising the step of immunizing an animal with the protein of claim 1 and recovering said antibody. 17. A method for producing an antibody, comprising the step of immunizing an animal with the protein of claim 7 and recovering said antibody. 18. A method for detecting CD8 receptors, comprising the steps of: (a) contacting a sample containing CD8 receptors with the protein of claim 1; and (b) detecting the CD8-protein complex. 19. A method for detecting CD8 receptors, comprising the steps of: (a) contacting a sample containing CD8 receptors with the protein of claim 7; and (b) detecting the CD8-protein complex. 20. A water soluble protein encoded by a transcript of a human MHC HLA-G gene, wherein said transcript comprises in succession from the 5' end to the 3' end: a sequence encoding the signal peptide; a sequence encoding the .alpha.1 domain; a sequence encoding the .alpha.3 domain, and intron 4, said transcript not including a sequence encoding the transmembrane domain. 21. A protein encoded by a transcript of the human MHC HLA-G gene, wherein said transcript comprises in succession from the 5' end to the 3' end: a sequence encoding the signal peptide; a sequence encoding the .alpha.1 domain; a sequence encoding the .alpha.2 domain; intron 4; a sequence encoding the transmembrane domain; a sequence encoding the cytoplasmic domain located on the 3' side of said sequence encoding the transmembrane domain.

Details for Patent 5,856,442

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2016-01-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2016-01-05
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2016-01-05
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.